PCN2 Data Analyses on Prevalence and Treatment of Acute Myeloid Leukaemia in Germany
Jörg Tomeczkowski(Janssen (Germany)), Christoph Tapprich(Johnson & Johnson (Germany)), Jochen Fleischmann(Janssen (Germany)), Thomas Mittendorf(Leibniz University of Applied Sciences), Ulrike Theidel
Cited by 0
Related Papers
German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus
|Value in Health|2008|173
Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany
|BMC Pediatrics|2009|89
Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings
|Bone Marrow Transplantation|2005|81
Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes
|Experimental Hematology|2008|58
The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective
|Health Economics Review|2012|42